Trends in antineoplastic drug use, cost and prescribing patterns among patients with lung cancer in nine major cities of China, 2016-2020: a retrospective observational study based on inpatient and outpatient hospital data.

ABSTRACT:

Objectives

It is unclear whether the use of antineoplastic drugs for patients with lung cancer in China has changed after the implementation of the national drug price negotiation in 2016 and continual update of clinical guidelines. This study aims to evaluate the trends in antineoplastic drug use, cost and prescribing patterns among patients with lung cancer in major cities of China.

Design

We conducted a retrospective observational study using data from January 2016 to December 2020.

Setting

This study used prescription records based on inpatient and outpatient hospital data from 97 hospitals in 9 major cities of China.

Participants

A total of 218 325 antineoplastic drug prescriptions in patients with lung cancer were retrospectively collected from the Hospit

SUBMITTER: Shang J 

PROVIDER: S-EPMC10030656 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature